RUNX2 Mediates Plasmacytoid Dendritic Cell Egress from the Bone Marrow and Controls Viral Immunity

Cell Reports

Volumn 15, Issue 4, 2016, Pages 866-878

  Chopin, Michaël ^a,b   Preston, Simon P ^a,b   Lun, Aaron T L ^a,b   Tellier, Julie ^a,b   Smyth, Gordon K ^a,b   Pellegrini, Marc ^a,b   Belz, Gabrielle T ^a,b   Corcoran, Lynn M ^a,b   Visvader, Jane E ^a,b   Wu, Li ^a,b,c   Nutt, Stephen L ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Tsinghua University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CHEMOKINE RECEPTOR CXCR4; INTEGRIN; INTERFERON REGULATORY FACTOR 7; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CD8+ T LYMPHOCYTE; CELL ADHESION; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RESPONSE; GENE DOSAGE; HAPLOINSUFFICIENCY; INTERFERON PRODUCTION; LYMPHOCYTIC CHORIOMENINGITIS; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; VIRAL CLEARANCE; VIRUS IMMUNITY;

EID: 84963544817     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.03.066     Document Type: Article

References (48)

1. Arsenio J., Kakaradov B., Metz P.J., Kim S.H., Yeo G.W., Chang J.T. Early specification of CD8+ T lymphocyte fates during adaptive immunity revealed by single-cell gene-expression analyses. Nat. Immunol. 2014, 15:365-372.
2. Battegay M., Cooper S., Althage A., Bänziger J., Hengartner H., Zinkernagel R.M. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J. Virol. Methods 1991, 33:191-198.
3. Beck T.C., Gomes A.C., Cyster J.G., Pereira J.P. CXCR4 and a cell-extrinsic mechanism control immature B lymphocyte egress from bone marrow. J. Exp. Med. 2014, 211:2567-2581.
4. Broxmeyer H.E., Orschell C.M., Clapp D.W., Hangoc G., Cooper S., Plett P.A., Liles W.C., Li X., Graham-Evans B., Campbell T.B., et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J. Exp. Med. 2005, 201:1307-1318.
5. Cella M., Jarrossay D., Facchetti F., Alebardi O., Nakajima H., Lanzavecchia A., Colonna M. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 1999, 5:919-923.
6. Cervantes-Barragan L., Züst R., Weber F., Spiegel M., Lang K.S., Akira S., Thiel V., Ludewig B. Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood 2007, 109:1131-1137.
7. Cervantes-Barragan L., Lewis K.L., Firner S., Thiel V., Hugues S., Reith W., Ludewig B., Reizis B. Plasmacytoid dendritic cells control T-cell response to chronic viral infection. Proc. Natl. Acad. Sci. USA 2012, 109:3012-3017.
8. Chopin M., Seillet C., Chevrier S., Wu L., Wang H., Morse H.C., Belz G.T., Nutt S.L. Langerhans cells are generated by two distinct PU.1-dependent transcriptional networks. J. Exp. Med. 2013, 210:2967-2980.
9. Cisse B., Caton M.L., Lehner M., Maeda T., Scheu S., Locksley R., Holmberg D., Zweier C., den Hollander N.S., Kant S.G., et al. Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 2008, 135:37-48.
10. Cooper S.C., Flaitz C.M., Johnston D.A., Lee B., Hecht J.T. A natural history of cleidocranial dysplasia. Am. J. Med. Genet. 2001, 104:1-6.
11. Crozat K., Guiton R., Guilliams M., Henri S., Baranek T., Schwartz-Cornil I., Malissen B., Dalod M. Comparative genomics as a tool to reveal functional equivalences between human and mouse dendritic cell subsets. Immunol. Rev. 2010, 234:177-198.
12. de la Rosa G., Longo N., Rodríguez-Fernández J.L., Puig-Kroger A., Pineda A., Corbí A.L., Sánchez-Mateos P. Migration of human blood dendritic cells across endothelial cell monolayers: adhesion molecules and chemokines involved in subset-specific transmigration. J. Leukoc. Biol. 2003, 73:639-649.
13. Ghosh H.S., Cisse B., Bunin A., Lewis K.L., Reizis B. Continuous expression of the transcription factor e2-2 maintains the cell fate of mature plasmacytoid dendritic cells. Immunity 2010, 33:905-916.
14. Gu X., Hu Z., Ebrahem Q., Crabb J.S., Mahfouz R.Z., Radivoyevitch T., Crabb J.W., Saunthararajah Y. Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy. J. Biol. Chem. 2014, 289:14881-14895.
15. Hervas-Stubbs S., Riezu-Boj J.I., Mancheño U., Rueda P., Lopez L., Alignani D., Rodríguez-García E., Thieblemont N., Leclerc C. Conventional but not plasmacytoid dendritic cells foster the systemic virus-induced type I IFN response needed for efficient CD8 T cell priming. J. Immunol. 2014, 193:1151-1161.
16. Honda K., Yanai H., Negishi H., Asagiri M., Sato M., Mizutani T., Shimada N., Ohba Y., Takaoka A., Yoshida N., Taniguchi T. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005, 434:772-777.
17. + T-cell development. Nat. Commun. 2013, 4:2830.
18. Jung A., Kato H., Kumagai Y., Kumar H., Kawai T., Takeuchi O., Akira S. Lymphocytoid choriomeningitis virus activates plasmacytoid dendritic cells and induces a cytotoxic T-cell response via MyD88. J. Virol. 2008, 82:196-206.
19. Kamogawa-Schifter Y., Ohkawa J., Namiki S., Arai N., Arai K., Liu Y. Ly49Q defines 2 pDC subsets in mice. Blood 2005, 105:2787-2792.
20. Kohara H., Omatsu Y., Sugiyama T., Noda M., Fujii N., Nagasawa T. Development of plasmacytoid dendritic cells in bone marrow stromal cell niches requires CXCL12-CXCR4 chemokine signaling. Blood 2007, 110:4153-4160.
21. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R.T., Gao Y.H., Inada M., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89:755-764.
22. Krug A., Uppaluri R., Facchetti F., Dorner B.G., Sheehan K.C., Schreiber R.D., Cella M., Colonna M. IFN-producing cells respond to CXCR3 ligands in the presence of CXCL12 and secrete inflammatory chemokines upon activation. J. Immunol. 2002, 169:6079-6083.
23. Liao Y., Smyth G.K., Shi W. The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Res. 2013, 41:e108.
24. Liles W.C., Broxmeyer H.E., Rodger E., Wood B., Hübel K., Cooper S., Hangoc G., Bridger G.J., Henson G.W., Calandra G., Dale D.C. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood 2003, 102:2728-2730.
25. Macal M., Lewis G.M., Kunz S., Flavell R., Harker J.A., Zúñiga E.I. Plasmacytoid dendritic cells are productively infected and activated through TLR-7 early after arenavirus infection. Cell Host Microbe 2012, 11:617-630.
26. Manh T.P., Alexandre Y., Baranek T., Crozat K., Dalod M. Plasmacytoid, conventional, and monocyte-derived dendritic cells undergo a profound and convergent genetic reprogramming during their maturation. Eur. J. Immunol. 2013, 43:1706-1715.
27. Marié I., Durbin J.E., Levy D.E. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J. 1998, 17:6660-6669.
28. Meyer M.B., Benkusky N.A., Pike J.W. The RUNX2 cistrome in osteoblasts: characterization, down-regulation following differentiation, and relationship to gene expression. J. Biol. Chem. 2014, 289:16016-16031.
29. Miller J.C., Brown B.D., Shay T., Gautier E.L., Jojic V., Cohain A., Pandey G., Leboeuf M., Elpek K.G., Helft J., et al. Deciphering the transcriptional network of the dendritic cell lineage. Nat. Immunol. 2012, 13:888-899. Immunological Genome Consortium.
30. Mundlos S., Otto F., Mundlos C., Mulliken J.B., Aylsworth A.S., Albright S., Lindhout D., Cole W.G., Henn W., Knoll J.H., et al. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 1997, 89:773-779.
31. Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., Rosewell I.R., Stamp G.W., Beddington R.S., Mundlos S., Olsen B.R., et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997, 89:765-771.
32. Owens T.W., Rogers R.L., Best S.A., Ledger A., Mooney A.M., Ferguson A., Shore P., Swarbrick A., Ormandy C.J., Simpson P.T., et al. Runx2 is a novel regulator of mammary epithelial cell fate in development and breast cancer. Cancer Res. 2014, 74:5277-5286.
33. Penna G., Vulcano M., Sozzani S., Adorini L. Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells. Hum. Immunol. 2002, 63:1164-1171.
34. Pereira J.P., An J., Xu Y., Huang Y., Cyster J.G. Cannabinoid receptor 2 mediates the retention of immature B cells in bone marrow sinusoids. Nat. Immunol. 2009, 10:403-411.
35. Petrovick M.S., Hiebert S.W., Friedman A.D., Hetherington C.J., Tenen D.G., Zhang D.E. Multiple functional domains of AML1: PU.1 and C/EBPalpha synergize with different regions of AML1. Mol. Cell. Biol. 1998, 18:3915-3925.
36. Rönnblom L., Forsgren A., Alm G.V. Characterization of interferons induced by bacteria and interferon-producing leukocytes in human peripheral blood. Infect. Immun. 1983, 40:126-132.
37. Satpathy A.T., Briseño C.G., Cai X., Michael D.G., Chou C., Hsiung S., Bhattacharya D., Speck N.A., Egawa T. Runx1 and Cbfβ regulate the development of Flt3+ dendritic cell progenitors and restrict myeloproliferative disorder. Blood 2014, 123:2968-2977.
38. Sawai C.M., Sisirak V., Ghosh H.S., Hou E.Z., Ceribelli M., Staudt L.M., Reizis B. Transcription factor Runx2 controls the development and migration of plasmacytoid dendritic cells. J. Exp. Med. 2013, 210:2151-2159.
39. Seibler J., Zevnik B., Küter-Luks B., Andreas S., Kern H., Hennek T., Rode A., Heimann C., Faust N., Kauselmann G., et al. Rapid generation of inducible mouse mutants. Nucleic Acids Res. 2003, 31:e12.
40. Siegal F.P., Kadowaki N., Shodell M., Fitzgerald-Bocarsly P.A., Shah K., Ho S., Antonenko S., Liu Y.J. The nature of the principal type 1 interferon-producing cells in human blood. Science 1999, 284:1835-1837.
41. Swiecki M., Gilfillan S., Vermi W., Wang Y., Colonna M. Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual. Immunity 2010, 33:955-966.
42. Swiecki M., Wang Y., Vermi W., Gilfillan S., Schreiber R.D., Colonna M. Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo. J. Exp. Med. 2011, 208:2367-2374.
43. Swiecki M., Wang Y., Gilfillan S., Colonna M. Plasmacytoid dendritic cells contribute to systemic but not local antiviral responses to HSV infections. PLoS Pathog. 2013, 9:e1003728.
44. Tailor P., Tamura T., Kong H.J., Kubota T., Kubota M., Borghi P., Gabriele L., Ozato K. The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8. Immunity 2007, 27:228-239.
45. Tassone L., Moratto D., Vermi W., De Francesco M., Notarangelo L.D., Porta F., Lougaris V., Facchetti F., Plebani A., Badolato R. Defect of plasmacytoid dendritic cells in warts, hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome patients. Blood 2010, 116:4870-4873.
46. Vanbervliet B., Bendriss-Vermare N., Massacrier C., Homey B., de Bouteiller O., Brière F., Trinchieri G., Caux C. The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12. J. Exp. Med. 2003, 198:823-830.
47. Wang Y., Swiecki M., Cella M., Alber G., Schreiber R.D., Gilfillan S., Colonna M. Timing and magnitude of type I interferon responses by distinct sensors impact CD8 T cell exhaustion and chronic viral infection. Cell Host Microbe 2012, 11:631-642.
48. Zlotnik A., Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000, 12:121-127.